To find out more about the #RIOtrial, check out short animated video link below. Credits: @HIViBase @AngelinaNamiba @ukcherub @sarahfidler4 @JohnFrater5 Will Everett, Hanna Box

Next up is Simon Collins @HIViBase who we're very privileged to have been part of the study from the very beginning as a community representative, sharing his insights on the importance of the study as well as community impact towards the study.

Prof @JohnFrater5 @NDMOxford completing the laboratory journey of the participants' samples, and how we can analyse virology and immunology data in depth from these samples.

It's a celebratory #RIOtrial participant feedback meeting today! As Prof @sarahfidler4 explains, recruitment has completed and we are closer to being able to report the first findings of the study by early next year.

Check out this paper by RIO researcher @TTipoe from @JohnFrater5 lab @NDMOxford. He reports how HIV-specific T cell responses in people with HIV are impacted by ATIs.

RT @jnim87: Pleased to see our meta-analysis of the impact of ATIs and trial interventions eg. #bNAbs, on time to….

#AIDS2024. @PennyZach1 and @jnim87 present their poster comparing #BNAB sensitivity prediction outcomes using blood or gut proviral DNA and rebound plasma RNA in people treated during primary HIV infection.

RT @JillianLau1: More #HIVcure posters at #AIDS2024. #bNAb sensitivity . testing in the @RIOtrial of long-acting 3BNC-117 and 10-1074 in P….

RT @JillianLau1: @sarahfidler4 from @imperialcollege starts her talk abt Key Partnerships for #HIVcure research w/ a primer on the contexts….

RT @iasociety: ▶️ Watch a free replay of our latest #webinar, "Analytical treatment interruptions in #HIV cure research", featuring IAS Pre….

To find out more about the #RIOtrial, visit

For those attending #BHIVA24, please check out the poster on understanding participants perspectives around HIV cure-related research involving ATIs in UK, presented by Dr Godakandaarachchi @GSTTnhs

@PennyZach1 @JohnFrater5 @NDMOxford report that 29% of a UK cohort of people treated in PHI had predicted resistance to 10-1074 by single genome Env sequence prediction algorithm. This highlights the need for bNAb resistance screening in clinical trials.

Dr Amanda Clarke and Caroline Cable from @BSUHresearch share their experiences working on the #RIOtrial. @UHSussex is one of our 12 clinical sites participating in the study!. To watch and find out more, visit 🌟💫

Watch Prof Sarah Fidler speak to Ms Louise Terry, a research nurse working on the #RIOtrial, to find out what's it like working on the study.

People living with HIV were surveyed on their views on joining studies like #RIOtrial which involving temporarily stopping ART (also known as ATIs). Read the paper by members of the RIO and HEATHER studies here! 🔽.

🎙️🎙️. Johan, who is currently participating in the #RIOtrial, kindly agreed to share his experiences and feelings with Prof. Sarah Fidler about pausing antiretroviral therapy (ART) as part of the trial. Watch the #ParticipantInterview now ⬆️.

RT @jnim87: Check out these eposters. at #EACS2023 . EP.A.061 attitude towards participation in cure trials which include a TI.EP.A.110 The….

Prof @SarahFidler7 gives an update on treatment interruption trials at #EACS2023

We're delighted to welcome the latest site offering the RIO study, based at the Churchill Hospital CCVTM in Oxford, bringing the total number of study sites to 12!

Missed #IAS2023?. Dr @jnim87 and colleagues discuss #RIOtrial and other exciting updates from the cobference, available on the @STI_BMJ podcast now!. 🔊.